Three additional product patents in the US for HyNap-Dasa
STOCKHOLM – February 18, 2020. Xspray Pharma (Nasdaq First North Growth Market: XSPRAY) announces that the United States Patent and Trademark Office (USPTO) has granted Xspray three new US patent for HyNap-Dasa. The new patents, US10,561,643; US 10,561,644; and US10,561,645, are valid until January 2033. This means that Xspray now has seven product patents for the pharmaceutical composition of the company's primary product candidate, HyNap-Dasa, in the company's main market USA.“With a total of seven patents for HyNap-Dasa in our most important market, we can justifiably state that it will